chartexchange

Tango and Erasca’s Phase I/II trial of ERAS-0015 combo opens for enrolment

Clinical Trials Arena | Nov 5, 2026 4:28 AM EST

Tango Therapeutics and Erasca have begun enrolment for a Phase I/II trial assessing the combination of oral therapies ERAS-0015 and vopimetostat in patients with lung and pancreatic cancers.
The post Tango and Erasca’s Phase I/II trial of ERAS-0015 combo opens for enrolment appeared first on Clinical Trials Arena .

Read original article